Treatment of Idiopathic calcium stone disease.
D000493:Allopurinol / Q000627:therapeutic use; D002129:Calcium Oxalate / Q000009:adverse effects*; D002136:Calcium, Dietary / Q000008:administration & dosage; D002482:Cellulose / Q000008:administration & dosage / Q000031:analogs & derivatives; D002951:Citrates / Q000627:therapeutic use; D019343:Citric Acid; D003131:Combined Modality Therapy; D005440:Fluid Therapy; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007669:Kidney Calculi / Q000601:surgery; D008274:Magnesium / Q000008:administration & dosage; D010070:Oxalates / Q000008:administration & dosage; D010710:Phosphates / Q000008:administration & dosage; D014545:Urinary Calculi / Q000209:etiology / Q000628:therapy*
D002136:Calcium, Dietary; D002951:Citrates; D010070:Oxalates; D010710:Phosphates; D006852:Hydrochlorothiazide; D002129:Calcium Oxalate; D019343:Citric Acid; D000493:Allopurinol; D002482:Cellulose; C008881:phosphocellulose; D008274:Magnesium